Loading market dashboard
Artelo Biosciences, Inc.
ARTLHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Artelo Biosciences, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $245.29M | $245.29M - $245.29M | $0.00 | $40.62 | 1 |
| Dec 2029 | $184.73M | $184.73M - $184.73M | $0.00 | $30.15 | 1 |
| Dec 2028 | $99.56M | $99.56M - $99.56M | $0.00 | $12.60 | 1 |
| Dec 2027 | $49.29M | $49.29M - $49.29M | $0.00 | -$5.28 | 1 |
| Dec 2026 | $0.00 | $0.00 - $0.00 | $0.00 | -$9.84 | 0 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$36.33 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$11.82 | 0 |